<?xml version="1.0" encoding="UTF-8"?>
<document id="29322326">
	<sentence id="s1" text="This study examined HS content and distribution in glioblastoma multiforme (GBM) tissues in the context of potential molecular mechanisms underlying its deregulation in brain tumours.">
		<entity id="s1.e1" charOffset="20-22"
			type="GENE" text="HS" ontology_id="9020"/>
		<entity id="s1.e2" charOffset="51-63"
			type="HP" text="glioblastoma" ontology_id="HP_0012174"/>
		<entity id="s1.e3" charOffset="175-181"
			type="HP" text="tumour" ontology_id="HP_0002664"/>
		<pair id="s1.p1" e1="s1.e1"
		    e2="s1.e2" pgr="false"/>
		<pair id="s1.p2" e1="s1.e1"
		    e2="s1.e3" pgr="false"/>
	</sentence>
	<sentence id="s2" text="HS expression was demonstrated in 50-55% of the GBM tumours by immunohistochemistry (IHC), while almost no HS content was detected in the surrounding paratumourous brain tissues.">
		<entity id="s2.e1" charOffset="0-2"
			type="GENE" text="HS" ontology_id="9020"/>
		<entity id="s2.e2" charOffset="52-58"
			type="HP" text="tumour" ontology_id="HP_0002664"/>
		<pair id="s2.p1" e1="s2.e1"
		    e2="s2.e2" pgr="false"/>
	</sentence>
	<sentence id="s3" text="Heterogeneous HS distribution in the HS-positive tumours was more related to the necrosis or glandular-like brain zones rather than glioma cells with high or low Ki-67 index.">
		<entity id="s3.e1" charOffset="14-16"
			type="GENE" text="HS" ontology_id="9020"/>
		<entity id="s3.e2" charOffset="49-55"
			type="HP" text="tumour" ontology_id="HP_0002664"/>
		<entity id="s3.e3" charOffset="162-164"
			type="GENE" text="Ki" ontology_id="10197"/>
		<pair id="s3.p1" e1="s3.e1"
		    e2="s3.e2" pgr="false"/>
		<pair id="s3.p2" e1="s3.e2"
		    e2="s3.e3" pgr="false"/>
	</sentence>
	<sentence id="s4" text="Taken together, the results indicate that increase of HS content and up-regulation of perlecan/HSPG2 expression in glioblastoma tissues contribute to tumour development through the transformation of brain extracellular matrix into tumour microenvironment, and represent negative prognostic factors for glioblastoma progression">
		<entity id="s4.e1" charOffset="54-56"
			type="GENE" text="HS" ontology_id="9020"/>
		<entity id="s4.e2" charOffset="86-94"
			type="GENE" text="perlecan" ontology_id="3339"/>
		<entity id="s4.e3" charOffset="115-127"
			type="HP" text="glioblastoma" ontology_id="HP_0012174"/>
		<entity id="s4.e4" charOffset="150-156"
			type="HP" text="tumour" ontology_id="HP_0002664"/>
		<pair id="s4.p1" e1="s4.e1"
		    e2="s4.e3" pgr="false"/>
		<pair id="s4.p2" e1="s4.e2"
		    e2="s4.e3" pgr="false"/>
		<pair id="s4.p3" e1="s4.e1"
		    e2="s4.e4" pgr="false"/>
		<pair id="s4.p4" e1="s4.e2"
		    e2="s4.e6" pgr="true"/>
	</sentence>
</document>
